SCHEMBL28813536

SCHEMBL28813536

C=CC(N1CCN(C)CC1)S(=O)(=O)c1ccc(N)c(O)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ CHRM2 P08172 1/20 0.34
▸ CHRM1 P11229 1/20 0.34
▸ HTT P42858 2/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ PTPN7 P35236 1/20 0.33
▸ DUSP3 P51452 1/20 0.33
▸ PTPN5 P54829 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ PTPN11 Q06124 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ DRD2 P14416 1/20 0.32
▸ DRD1 P21728 1/20 0.32
▸ DRD5 P21918 1/20 0.32
▸ CCNE2 O96020 1/20 0.32
▸ CCNE1 P24864 1/20 0.32
▸ CDK2 P24941 1/20 0.32
▸ GSK3B P49841 1/20 0.32
▸ CA1 P00915 4/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27951598 0.89 CHRM2 (0.36) ALDH1A1CHRM2CHRM1HTTMEN1
SCHEMBL27593641 0.82 ALDH1A1 (0.39) ALDH1A1CHRM2CHRM1KMT2APOLB
SCHEMBL27593507 0.82 CHRM2 (0.39) ALDH1A1HSD17B10CHRM2CHRM1HTT
SCHEMBL27669965 0.80 ADRA2C (0.42) ALDH1A1HSD17B10CHRM2CHRM1HTT
SCHEMBL27605812 0.77 PARG (0.40) CHRM2CHRM1HTTMEN1KMT2A
SCHEMBL27788104 0.76 CHRM2 (0.50) CHRM2CHRM1POLBDRD2DRD1
SCHEMBL27845916 0.76 SMN1; SMN2 (0.40) ALDH1A1CHRM2CHRM1HTTMEN1
SCHEMBL27913253 0.74 CASP3 (0.41) —
SCHEMBL28751217 0.73 L3MBTL1 (0.49) ALDH1A1MEN1KMT2ACA1CA2
SCHEMBL27745075 0.71 CA1 (0.43) ALDH1A1HTTMEN1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103958505-A Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated pathologies GALDERMA RES & AMP 2014-07-30 — — CN disclosed
Send feedback